Home › Funds › TWIN FOCUS CAPITAL PARTNERS, LLC › CGEM

TWIN FOCUS CAPITAL PARTNERS, LLC position in CGEM

CULLINAN THERAPEUTICS INC · Health Care

TWIN FOCUS CAPITAL PARTNERS, LLC reported holding 595,489 shares of CGEM (CULLINAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.1M, representing 0.85% of its reported portfolio and ranking #29 among its reported holdings. TWIN FOCUS CAPITAL PARTNERS, LLC has disclosed CGEM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)595.49K sh
Reported value held$9.14M
Portfolio Weight0.85%
First reportedQ2 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How TWIN FOCUS CAPITAL PARTNERS, LLC's CGEM position evolved

TWIN FOCUS CAPITAL PARTNERS, LLC first disclosed a stake in CGEM in Q2 2024 at 595,489 shares (US$10.4M). The position peaked in Q2 2026 at 595,489 shares, worth US$10.8M. Across 10 filings, TWIN FOCUS CAPITAL PARTNERS, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 595,489 shares valued at US$9.1M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 595.49K $10.39M New
Q3 2024 595.49K $9.97M Hold
Q4 2024 595.49K $7.25M Hold
Q1 2025 595.49K $4.51M Hold
Q2 2025 595.49K $4.48M Hold
Q3 2025 595.49K $3.53M Hold
Q4 2025 595.49K $6.16M Hold
Q1 2026 595.49K $8.46M Hold
Q2 2026 595.49K $10.84M Hold
Q3 2026 595.49K $9.14M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGEM and 13F data

CGEM (CULLINAN THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in CGEM — the largest reported positions include MPM BioImpact LLC (US$177.2M), Lynx1 Capital Management LP (US$163.2M), BVF INC/IL (US$104.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGEM

All CGEM fund holders →

FAQ

How long has TWIN FOCUS CAPITAL PARTNERS, LLC held CGEM?

TWIN FOCUS CAPITAL PARTNERS, LLC has disclosed CGEM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is TWIN FOCUS CAPITAL PARTNERS, LLC's current position in CGEM?

As of Q3 2026, TWIN FOCUS CAPITAL PARTNERS, LLC holds 595.49K shares of CGEM (CULLINAN THERAPEUTICS INC), valued at $9.14M, representing 0.85% of its reported portfolio and ranking #29.

Has TWIN FOCUS CAPITAL PARTNERS, LLC been buying or selling CGEM?

In the latest 13F filing (Q3 2026), TWIN FOCUS CAPITAL PARTNERS, LLC held unchanged its position in CGEM. The position peaked in Q2 2026 at 595.49K shares.

Which other funds hold CGEM?

Other major institutional holders of CGEM include MPM BioImpact LLC, Lynx1 Capital Management LP, BVF INC/IL, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.